Can Patients' Likelihood of Benefiting from Primary Chemotherapy for Breast Cancer Be Predicted Before Commencement of Treatment?

By Ogston Keith   Miller Iain   Schofield Andrew   Spyrantis Andreas   Pavlidou Eleni   Sarkar Tarun   Hutcheon Andrew   Payne Simon   Heys Steven  

Breast Cancer Research and Treatment, Vol. 86, Iss. 2, 2004-07 ,pp. : 181-189

Springer Publishing Company

Access to resources Recommend Favorite

Does Regional Treatment Improve the Survival in Patients with Operable Breast Cancer?

By Noguchi M.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 3, 2002-12 ,pp. : 269-282

Springer Publishing Company

Access to resources Recommend Favorite

Duration of Chemotherapy for Early Stage Breast Cancer: Have We Reached the Limit? What is the Survival Impact of Amenorrhea?

By Hirsh Rebecca  

Current Treatment Options in Oncology, Vol. 11, Iss. 3-4, 2010-12 ,pp. : 59-62

Springer Publishing Company

Access to resources Recommend Favorite

Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?

By Gerber Bernd  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 613-624

Springer Publishing Company

Access to resources Recommend Favorite

Reply to preoperative PET/CT in early-stage breast cancer: is the TNM classification enough?

By Bernsdorf M.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 852-853

Oxford University Press

Access to resources Recommend Favorite